✦ LIBER ✦

Low-n oligomers as therapeutic targets of Alzheimer’s disease

✍ Scribed by Kenjiro Ono; Masahito Yamada

Book ID: 111184410
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 245 KB
Volume: 117
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2011.07187.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

49 Aβ oligomers as diagnostic and therap

49 Aβ oligomers as diagnostic and therapeutic targets for Alzheimer's disease

✍ Colin Masters; B. Robert; T. Ryan; M. Lind; Q.-X. Li; A. Watt; R. Cherny; K. Bar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Secretases as therapeutic targets for Al

Secretases as therapeutic targets for Alzheimer’s disease

✍ Ha-Na Woo; Sang-Ha Baik; Jong-Sung Park; A-Ryeong Gwon; Sunghee Yang; Young-Kwan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 297 KB

Phosphodiesterases as Therapeutic Target

Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease

✍ García-Osta, Ana; Cuadrado-Tejedor, Mar; García-Barroso, Carolina; Oyarzábal, Ju 📂 Article 📅 2012 🏛 American Chemical Society 🌐 English ⚖ 755 KB

Tau modifiers as therapeutic targets for

Tau modifiers as therapeutic targets for Alzheimer's disease

✍ Quan Liu; Hyoung-gon Lee; Kazuhiro Honda; Sandra L. Siedlak; Peggy L.R. Harris; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Hypometabolism as a therapeutic target i

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

Hypometabolism as a therapeutic target i

Hypometabolism as a therapeutic target in Alzheimer's disease

✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. Thi